Obesity drug competition expected to intensify by 2030
Drug Discovery World
AUGUST 2, 2024
This translates to a placebo-adjusted weight loss from baseline of 7.4%, 9.2%, 11.3%, and 13.10% in the treatment groups. Diana Spencer, Senior Digital Content Editor, DDW The post Obesity drug competition expected to intensify by 2030 appeared first on Drug Discovery World (DDW). placebo-adjusted mean weight loss (5.3%
Let's personalize your content